Skip to main content
PROTEOME SCIENCES PLC logo

PROTEOME SCIENCES PLC — Investor Relations & Filings

Ticker · PRM ISIN · GB0003104196 LEI · 213800Q62ICXANKU2986 IL Professional, scientific and technical activities
Open in API
Filings indexed 279 across all filing types
Latest filing 2013-06-28 Legal Proceedings Report
Country GB United Kingdom
Listing IL PRM

About PROTEOME SCIENCES PLC

https://www.proteomics.com/

Proteome Sciences PLC is a specialized Contract Research Organization (CRO) focused on applied proteomics and peptidomics. The company provides comprehensive mass spectrometry-based analytical services to support drug discovery, development, and biomarker identification for precision medicine. Its services cover the full workflow from sample preparation and proteome characterization to bioinformatics data interpretation and reporting, handling diverse biological samples. A key offering is its proprietary TMT® and TMTpro® isobaric tags, which the company invented, developed, and exclusively manufactures for multiplexed protein quantification. These reagents are distributed globally to the mass spectrometry community. The company serves the biopharmaceutical sector, operating under ISO 9001:2015 and Good Clinical Laboratory Practice (GCLP) standards for its targeted assays.

Recent filings

Filing Released Lang Actions
Patent Statement
Legal Proceedings Report Classification · 1% confidence The document is very short (3354 characters) and is explicitly marked with an 'RNS Number' and ends with 'This information is provided by RNS The company news service from the London Stock Exchange'. The content addresses a specific, time-sensitive matter (patent portfolio concerns following court rulings) and provides an update, which is characteristic of a general regulatory announcement rather than a comprehensive report (like 10-K or IR) or a specific event material (like AGM-R or IP). Since it is a general regulatory announcement that doesn't fit the other specific categories (like DIRS, DIV, or MANG), the most appropriate classification is the general regulatory filing fallback category, RNS.
2013-06-28 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with 'RNS Number : 8921H' and contains the header 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES'. This format is characteristic of regulatory notifications concerning changes in major shareholdings, which aligns with the definition for Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content (TR-1 form detailing shareholding changes crossing the 5% threshold) makes MRQ the most precise classification. The document length is moderate (6411 chars), suggesting it is the filing itself, not just an announcement of a filing.
2013-06-26 English
Major technology contract
Legal Proceedings Report Classification · 1% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement disseminated via the London Stock Exchange's news service (RNS). The content details a significant business development: a technology agreement/contract with Thermo Fisher Scientific regarding cancer pathway profiling assays. This is a material event announcement, but it does not fit neatly into specific categories like Earnings Release (ER), Capital Update (CAP), or Director's Dealing (DIRS). Since it is a general, material announcement distributed through the RNS system and doesn't perfectly match the definitions for the more specific codes (like DEF 14A for remuneration or MRQ for shareholding changes), the most appropriate fallback category is Regulatory Filings (RNS). The document length (5827 chars) is substantial enough that it is the announcement itself, not just a notice of publication (RPA).
2013-06-12 English
Annual Financial Report
Report Publication Announcement Classification · 1% confidence The document is very short (2882 characters) and explicitly states that the 'Annual Report & Accounts for the year ended 31st December 2012 have today been posted to shareholders and a copy is available to view on the Company's website.' This structure—announcing the availability of a full report without containing the report's substance—fits the definition of a Report Publication Announcement (RPA). Although it mentions the 'Annual Report & Accounts', the document itself is merely the notification, not the comprehensive 10-K filing. The RNS number confirms it is a regulatory announcement.
2013-06-05 English
Preliminary Results
Earnings Release Classification · 1% confidence The document is titled 'Preliminary results for the year ended 31st December, 2012' and contains detailed financial highlights (Revenue, Loss after tax, Cash balances) and operational reviews for the full fiscal year 2012. It explicitly mentions attached documents like the 'consolidated income statement, consolidated balance sheet, consolidated statement of changes in equity, consolidated cashflow statement and notes to the financial statements.' This structure strongly indicates a comprehensive annual financial report, which corresponds to the 10-K filing type, even though it is presented via an RNS announcement format. Since the content is the full set of preliminary annual results and financial statements, it is classified as the Annual Report (10-K) rather than just an Earnings Release (ER) or Report Publication Announcement (RPA). The RNS number suggests it was disseminated via the regulatory news service, but the core content is the annual results. FY 2012
2013-05-30 English
Trading Update
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and the issuer 'Proteome Sciences PLC', followed by a date and the title 'Trading Update'. The content discusses a business development related to EU cosmetic testing regulations and the selection of the company's SensiDerm™ assays, along with an update on a loan agreement. The presence of the RNS Number and the nature of the announcement (a material business update that is not a full financial report, dividend notice, or management change) strongly indicates this is a general regulatory announcement disseminated via the London Stock Exchange's Regulatory News Service (RNS). Although it contains business updates, it is not a formal Earnings Release (ER) or Interim Report (IR). Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for such announcements.
2013-04-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.